Literature DB >> 19669294

New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response.

Dilip Ratnam1, Kumar Visvanathan.   

Abstract

Acute and chronic infection with hepatitis B virus (HBV) is associated with an increased risk of developing liver disease including cirrhosis, decompensated liver disease, and hepatocellular carcinoma. The clinical presentation and natural history of HBV infection is mediated through complex interactions between the virus and the host immune response. HBV is not directly cytopathic to heptocytes; however, the interaction between the virus and the host immune response plays a central role in the pathogenesis of necroinflammation and liver fibrosis. Emerging data from immunopathogenesis studies in animal models and in vitro studies of liver biopsies from patients with chronic hepatitis B demonstrate a potentially important interaction between hepatitis B e antigen, HBV, and components of the innate immune response including Toll-like receptors, Kupffer cells, natural killer T-cells, and dendritic cells. These findings suggest that the innate immune response has an important role in influencing the outcome of acute and chronic HBV infection. The current knowledge regarding the interaction between HBV and components of the innate immune response during acute and chronic HBV infection is reviewed.

Entities:  

Year:  2008        PMID: 19669294      PMCID: PMC2716839          DOI: 10.1007/s12072-008-9067-0

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  65 in total

Review 1.  Toll-like receptor signaling.

Authors:  Shizuo Akira
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

Review 2.  Innate sensing of viruses by toll-like receptors.

Authors:  Karl W Boehme; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

4.  Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.

Authors:  G L Su; R D Klein; A Aminlari; H Y Zhang; L Steinstraesser; W H Alarcon; D G Remick; S C Wang
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

6.  Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.

Authors:  E Seki; H Tsutsui; H Nakano; N Tsuji; K Hoshino; O Adachi; K Adachi; S Futatsugi; K Kuida; O Takeuchi; H Okamura; J Fujimoto; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

7.  Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Authors:  Renate G van der Molen; Dave Sprengers; Rekha S Binda; Esther C de Jong; Hubert G M Niesters; Johannes G Kusters; Jaap Kwekkeboom; Harry L A Janssen
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

8.  Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.

Authors:  Yongyan Chen; Haiming Wei; Rui Sun; Zhongjun Dong; Jian Zhang; Zhigang Tian
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

10.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

View more
  6 in total

Review 1.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection.

Authors:  Yun-Fan Liaw; George K K Lau; Jia-Horng Kao; Edward Gane
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

3.  Overt Acute Hepatitis B Deteriorates in Females: Destructive Immunity With an Exaggerated Interleukin-17 Pathway.

Authors:  Ming-Ling Chang; Chau-Ting Yeh; Rong-Nan Chien; Yun-Fan Liaw
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

4.  Clinical features and outcome of acute hepatitis B in pregnancy.

Authors:  Yong-Tao Han; Chao Sun; Cai-Xia Liu; Shuang-Shuang Xie; Di Xiao; Li Liu; Jin-Hong Yu; Wen-Wen Li; Qiang Li
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

5.  Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a.

Authors:  Zhaohua Hou; Jian Zhang; Qiuju Han; Chenhe Su; Jing Qu; Dongqing Xu; Cai Zhang; Zhigang Tian
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

6.  Kinetic Changes of Viremia and Viral Antigens of Hepatitis B Virus During and After Pregnancy.

Authors:  Jingli Liu; Yongchun Bi; Chenyu Xu; Lanhua Liu; Biao Xu; Tingmei Chen; Jie Chen; Mingjie Pan; Yali Hu; Yi-Hua Zhou
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.